Non-interventional study to evaluate Arimidex in postmenopausal women with advanced breast cancer

Study identifier:NIS-ARO-HCH-2006/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

ARIMIDEX Study ( Non-interventional study to evaluate Arimidex in adjuvant therapy in partial or complete response or stabilized disease after first line chemotherapy in postmenopausal women with advanced breast cancer)

Medical condition

Advanced breast cancer

Phase

-

Healthy volunteers

No

Study drug

-

Sex

Female

Actual enrollment

200

Study type

Observational

Age

N/A

Date

Study Start Date: 01 Dec 2006
Primary Completion Date: -
Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria